Cardiovascular Systems Inc(CSII) Finding the best opportunities to buy and sell stocks daily.

Sector:

Healthcare

Description:

Cardiovascular Systems, Inc., a medical device company, develops and commercializes various devices to treat peripheral and coronary artery diseases in the United States. The company offers peripheral artery disease products, which are catheter-based platforms to treat a range of plaque types in above and below the knee leg arteries, including calcified plaque, as well as address various limitations related with surgical, catheter, and pharmacological treatment alternatives; and peripheral support products. It also provides Diamondback 360 Coronary orbital atherectomy systems (OAS), a coronary artery disease (CAD) product designed to facilitate stent delivery in patients with CAD who are acceptable candidates for percutaneous transluminal coronary angioplasty or stenting due to severely calcified coronary artery lesions. The company was founded in 1989 and is headquartered in St. Paul, Minnesota.

Current Price

$35.47

RSI

7.974

Beta:

0.817981

February 04, 2021
20.7M
835K

-6.010 %
-10.213 %
100.209 %
-3.498 %

$234,402,000
$246,291,000
$215,310,000
$204,110,000
$177,869,000
$181,544,000
-5.072 %
14.389 %
5.487 %
14.753 %
-2.066 %

$-27,005,000
$-65,000
$1,844,000
$-1,706,000
$-55,932,000
$-32,822,000
-99.759 %
-2936.923 %
192.516 %
3178.546 %
-41.318 %

News

Press Releases

Notable Dates

All stock recommendations and comments are all opinions. Investors should be cautious about any and all stock recommendations and should consider the source of any advice on stock selection. Various factors, including personal ownership, may influence or factor into a stock analysis or opinion. All investors are advised to conduct their own independent research into individual stocks before making a purchase decision. In addition, investors are advised that past stock performance is not indicative of future price action.